title: Helicobacter pylori infection and antioxidants can modulate the genotoxic effects of heterocyclic amines in gastric mucosa cells.
abstract: Helicobacter pylori (H. pylori) infection plays an important role in gastric carcinogenesis. This bacterium may induce cancer transformation and change the susceptibility of gastric mucosa cells to various exogenous dietary irritants. The aim of the study was to evaluate the influence of H. pylori infection on the reaction of the stomach cells to a genotoxic effect of heterocyclic amines (HCAs). These well-known mutagens are formed during cooking of protein-rich foods, primarily meat. Taking into account that persons consuming a mixed-western diet are exposed to these compound nearly an entire lifetime and more than half of human population is infected with H. pylori, it is important to assess the combined effect of H. pylori infection and HCAs in the context of DNA damage in gastric mucosa cells, which is a prerequisite to cancer transformation. We employed 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline (MeIQx) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) because these substances are present in a great amount in cooked and fried meat. Using alkaline comet assay, we showed that the extent of the DNA damage induced by HCAs was significantly higher in H. pylori infected gastric mucosa cells than in non-infected counterparts. We did not observed any difference in the efficiency of repair of DNA lesions induced by HCAs in both type of cells. Vitamin C reduced the genotoxic effects of HCAs in H. pylori infected and non-infected gastric mucosa cells. Melatonin more effectively decreased DNA damage caused by HCAs in H. pylori infected gastric mucosa cells as compared with control. Our results suggest that H. pylori infection may influence the susceptibility of gastric mucosa cells to HCAs and dietary antioxidative substances, including vitamin C and melatonin may inhibit the genotoxic effects of HCAs on gastric mucosa cells and may reduce the risk of carcinogenesis caused by food borne mutagens and H. pylori infection.
authors: Department of Molecular Genetics, University of Lodz, Lodz, Poland. tplas@biol.uni.lodz.pl
authors: Tomasz
authors: T
authors: Poplawski
authors: Cezary
authors: C
authors: Chojnacki
authors: Anna
authors: A
authors: Czubatka
authors: Grazyna
authors: G
authors: Klupinska
authors: Jan
authors: J
authors: Chojnacki
authors: Janusz
authors: J
authors: Blasiak
mesh_terms: D000328:Adult; D001205:Ascorbic Acid / Q000494:pharmacology; D001944:Breath Tests; D002247:Carbon Isotopes / Q000378:metabolism; D020552:Comet Assay; D004249:DNA Damage / Q000187:drug effects / Q000235:genetics*; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects* / Q000382:microbiology; D016481:Helicobacter Infections / Q000378:metabolism*; D016480:Helicobacter pylori; D006801:Humans; D007093:Imidazoles / Q000633:toxicity*; D008297:Male; D008550:Melatonin / Q000494:pharmacology; D008875:Middle Aged; D011044:Poland; D011810:Quinoxalines / Q000633:toxicity*; D018709:Statistics, Nonparametric
chemical_list: D002247:Carbon Isotopes; D007093:Imidazoles; D011810:Quinoxalines; C036990:2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline; C049584:2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine; D008550:Melatonin; D001205:Ascorbic Acid
references: Carcinogenesis. 1986 Jul;7(7):1081-6
references: 3719903
references: EMBO J. 2000 Dec 1;19(23):6361-70
references: 11101509
references: Am J Physiol. 1992 Nov;263(5 Pt 1):G719-25
references: 1443147
references: Cell Microbiol. 2004 Feb;6(2):143-54
references: 14706100
references: Mutat Res. 2005 Feb 15;570(1):129-35
references: 15680410
references: Exp Cell Res. 1988 Mar;175(1):184-91
references: 3345800
references: Cell Mol Biol Lett. 2006;11(4):570-8
references: 17028789
references: Toxicol Sci. 2000 Mar;54(1):19-29
references: 10746928
references: Infect Immun. 2007 Aug;75(8):4030-9
references: 17562777
references: J Biol Chem. 2004 Feb 20;279(8):7024-8
references: 14630932
references: Nutr Cancer. 2002;43(1):103-10
references: 12467141
references: Drug Metab Rev. 1999 Nov;31(4):917-70
references: 10575555
references: Mutat Res. 1996 Jun 12;363(2):89-96
references: 8676929
references: Hepatogastroenterology. 2010 Mar-Apr;57(98):372-6
references: 20583446
references: J Pineal Res. 2004 Jan;36(1):1-9
references: 14675124
references: Science. 2003 Aug 22;301(5636):1099-102
references: 12934009
references: Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):631-7
references: 15066929
references: Helicobacter. 2002 Oct;7(5):271-80
references: 12390206
references: Gut. 1998 Sep;43(3):322-6
references: 9863475
references: Gut. 2002 Feb;50(2):165-9
references: 11788554
references: Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):238s-241s
references: 12646518
references: Neuro Endocrinol Lett. 2008 Oct;29(5):609-13
references: 18987585
references: Chem Res Toxicol. 1998 Aug;11(8):925-36
references: 9705755
references: Mutat Res. 1997 May 12;376(1-2):211-9
references: 9202758
references: Carcinogenesis. 2008 Dec;29(12):2400-5
references: 18784355
references: Mutat Res. 1997 May 12;376(1-2):37-41
references: 9202736
references: Chem Res Toxicol. 1992 Jul-Aug;5(4):479-90
references: 1391614
references: Nat Rev Microbiol. 2005 Apr;3(4):320-32
references: 15759043
references: Mutat Res. 2009 Jul 10;667(1-2):142-57
references: 19563929
references: J Clin Gastroenterol. 2007 Mar;41(3):270-4
references: 17426465
references: Chem Biol Interact. 2009 Jun 15;180(1):69-78
references: 19428346
references: Mutat Res. 2001 Oct 1;482(1-2):3-10
references: 11535243
references: IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
references: 7715068
references: J Pineal Res. 2005 Sep;39(2):99-104
references: 16098085
references: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2001-6
references: 10051584
references: Carcinogenesis. 1995 Jan;16(1):39-52
references: 7834804
references: EMBO J. 1999 Oct 15;18(20):5517-27
references: 10523296